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2,2-Bis(4-hydroxyphenyl)propane (bisphe-
nol A; BPA) has been used in the manufac-
ture of polycarbonate and epoxy resins and
other plastics (polysulfone, alkylphenolic,
polyalylate, polyester-styrene, and certain
polyester resins) and has also been used as a
fungicide, antioxidant, ﬂame retardant, rub-
ber chemical, and polyvinyl chloride stabiliz-
er. Polycarbonate resins are employed in
food-contact uses as in components of food
processors; microwave oven-ware; tableware;
refrigerator crisper drawers; food-storage
containers; returnable water, milk, and juice
containers; feeding bottles for infants; 
and interior coatings of cans and drums.
Polycarbonate and these other resins are also
used as ﬁlms, sheets, and laminations; rein-
forced pipes; floorings; watermain filters;
enamels and vanishes; adhesives; artificial
teeth; nail polish; compact discs; electric insu-
lators; and as parts of automobiles, certain
machines, tools, electrical appliances, and
ofﬁce automation instruments. The estimated
average annual production of BPA in Japan
for 1995 was approximately 260,000 tons (1),
and the production of polycarbonate and
epoxy resins for 1998 was approximately
317,000 and 204,000 tons, respectively (2).
Release and migration of BPA monomer
from polycarbonate tableware, baby bottles,
and cans coated with epoxy or polyvinylchlo-
ride resins have been recognized (3–5). A
small amount of BPA is detectable in tap
water and river water (6–8).
An excess dose of BPA (5.5–6.3 g/kg/day)
is nephrotoxic in mice (9), but BPA is neither
carcinogenic nor teratogenic (10,11). In vivo
estrogenic activities (400–1,000 mg/kg/day)
in immature or ovariectomized rats and mice
have been recognized (12–14). Reduction of
epididymal weight, seminal vesicle weight,
and sperm motility in F0 and F1 mice given a
large dose of BPA (437–1,750 mg/kg/day)
has been also observed (15). Recently, it has
been reported that low doses of BPA in utero
(2–400 µg/kg/day) can be toxic in reproduc-
tive organs of male offspring of mice and rats
(16–18). Cagen et al. (19,20) attempted to
repeat the study, but they have not been able
to reproduce the results. Therefore, the toxici-
ty of low doses of BPA on male reproductive
organs remains controversial. 
Knaak and Sullivan (21) reported that
most of an orally administered dose of 14C-
BPA was excreted in feces and urine in rats
within 24 hr. Over 8 days, 28% of the 14C
was excreted in urine and 56% in feces. The
BPA was excreted in urine as glucuronide or
in feces as free BPA, hydroxylated BPA, and
a conjugate (21). Some preliminary reports
indicate that the metabolism of BPA is dif-
ferent based on the route of administration
(22). BPA is distributed in mouse fetuses
(23) and in human umbilical cords (24).
However, there have been few reports on
disposition of BPA.
In the present study we examine the dis-
position of orally administered BPA in preg-
nant rats and the placental transfer to fetuses.
The purpose of this experiment was to know
whether or not BPA could be easily distrib-
uted to fetuses.
Materials and Methods
Chemicals. We purchased BPA (> 95.0%
pure) and propylene glycol (practical grade)
from Wako Pure Chemical Company
(Osaka, Japan). Acetone, n-hexane (for pesti-
cide residue analysis), methanol, and acetoni-
trile (for HPLC) were obtained from Kanto
Chemicals Co., Inc. (Tokyo, Japan).
Animals and administration. Pregnant
female F344/DuCrj (Fischer) rats, 10 weeks
old, were purchased from Japan Charles
River (Yokohama, Japan) on day 4 of gesta-
tion; the day vaginal plugs were observed was
considered day 0 of gestation. Rats were indi-
vidually housed in stainless steel suspended
cages and fed a standard diet (CLEA CE-2;
CLEA Japan Inc., Tokyo, Japan) in an air-
conditioned room at 25±1°C with a relative
humidity of 55±5%. F344 rats are widely
used for many toxicology studies and car-
cinogenesis bioassays (10); because they are
thought to be estrogen-sensitive (25), we
chose this strain for the present study.
On day 18 of gestation, rats were orally
administered BPA dissolved in propylene
glycol (25%, wt/v) at a dose of 1 g/kg. This
dose is approximately one-fourth the median
lethal dose (LD50) for rats (26). 
We conducted the experiment under ethi-
cal consideration for experimental animals
from the standpoint of animal welfare accord-
ing to the “Guiding Principles for the Care
and Use of Laboratory Animals,” approved by
the Japanese Pharmacological Society (27)
and by the Tokyo Metropolitan Research
Laboratory of Public Health (28). This study
was approved by the Committee of Animal
Experiments in the Tokyo Metropolitan
Research Laboratory of Public Health. 
BPA analysis. Rats were killed by decapi-
tation 10, 20, 30, and 40 min and 1, 2, 4, 6,
12, 24, and 48 hr after administration. After
collection of blood, fetuses were removed and
then maternal kidneys and livers were dissect-
ed out. The study included two to six moth-
ers per time point (three animals for 10, 20,
and 40 min and for 6 and 12 hr; two animals
for 30 min and 1, 2, and 4 hr; six animals for
24 hr; and four animals for 48 hr). We used
8–12 fetuses from two to three mothers per
time point (12 fetuses for 10 and 20 min and
12 and 24 hr; 10 fetuses for 40 min; and 8
fetuses for 1, 2, 4, 6, and 48 hr). Generally,
we used only fetuses attached to the ovarian
and cervical ends of both right and left uter-
ine horns of a mother (4 fetuses) for analyses.
We used a Polytron homogenizer
(Kinematica GmbH, Lucerne, Switzerland)
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Articles
We studied the disposition of bisphenol A (BPA) in pregnant female F344/DuCrj(Fischer) rats
and its placental transfer to fetuses after a single oral administration of 1 g/kg BPA dissolved in
propylene glycol. BPA in maternal blood, liver, and kidney reached maximal concentrations
(14.7, 171, and 36µg/g) 20 min after the administration and gradually decreased. The levels were
2–5% of the maximum 6 hr after the administration. The maximal concentration of BPA in
fetuses (9 µg/g) was also attained 20 min after the administration. BPA levels then gradually
reduced in a similar manner to maternal blood. These results suggest that the absorption and dis-
tribution of BPA in maternal organs and fetuses are extremely rapid and that the placenta does
not act as a barrier to BPA. Key words: bisphenol A, fetus, placenta, placental transfer. Environ
Health Perspect 108:931–935 (2000). [Online 12 September 2000]
http://ehpnet1.niehs.nih.gov/docs/2000/108p931-935takahashi/abstract.htmland acetone (1 g tissue/20 mL acetone) to
homogenize maternal organs and whole
fetuses. After centrifugation, the acetone
extracts were dried at 40°C under a stream of
nitrogen. Because these acetone extracts con-
tained many contaminants to disturb the
analysis of BPA, we added 1 volume of water
and then 1 or 2 volumes n-hexane to the
extracts and vigorously mixed them to
exclude the contaminants into the water
layer. After centrifugation, the hexane
extracts were dried under a stream of nitro-
gen and dissolved in methanol because of the
solubility of BPA in methanol and the misci-
bility of methanol solution to the mobile
phase. We analyzed BPA in methanol solu-
tion by HPLC using a Mightysil RP-18 (150
× 4.6mm) column (Lot 98M1019; Kanto
Chemical Co., Inc., Tokyo) eluted with ace-
tonitrile:water (35:65) at a ﬂow rate of 1.0
mL/min by a Toso CCPE pump (Toyo
Soda, Tokyo, Japan) and detected by a
Shimadzu SPD-6AV UV-VIS spectrophoto-
metric detector (Shimadzu Corp., Kyoto,
Japan) or by a Toso UV-8020 detector
(Toyo Soda, Tokyo, Japan) at a wavelength
of 227 nm. We determined BPA using an
external standard. We evaluated the accuracy
and validity of this method using > 95%
pure BPA. The retention time of BPA was
16.6–16.7 min or 17.1–17.2 min [when
another Mightysil RP-18 column (Lot
99M0212) and another pump and detector
were used]. The calibration curve was linear
from 0.005 to 54 µg/g. 
To recover BPA from organs, we con-
ducted experiments using liver, which possi-
bly contained biologic materials that can
interfere with analysis. The average recovery
of BPA from liver in these procedures was
87.45 ± 5.73% (mean ± SD). There was no
peak of biologic materials that interfered
with the determination of BPA. The vari-
ance of measurement was within approxi-
mately 5%. The injection volume was
1.0–10.0 µL. To determine BPA in organs,
we compared the peak area with that of 95%
pure BPA, which was freshly prepared daily
and frequently used for calibration. The
detection limit was 0.005 µg/g. No BPA was
detected in organs of rats administered
propylene glycol (vehicle) at a dose of only 4
mL/kg. Figure 1 shows a chromatogram of
BPA in fetuses.
Data analysis. Data are expressed as
mean ± SD. We used model-independent
analysis to determine the toxicokinetic para-
meters (29). The area under the tissue con-
centration-time curve (AUC) was calculated
by the trapezoidal method. We calculated
mean residence time (MRT) and variance of
residence time (VRT) from AUC values
(30). Biologic half-lives of organs were esti-
mated by a least-squares fit from the
descending portion of the semilogarithmic
plot of concentration versus time. We read
the multiple linear descending portions, so
we calculated two or three different biologic
half-lives by this method. 
Results
Changes in BPA concentrations in maternal
blood, liver, and kidney. BPA (2.89 µg/g)
was already in maternal blood 10 min after
dosing (Figure 2), and reached a maximal
concentration (14.7 µg/g) 20 min after dos-
ing. The maximal level was 0.007% of the
administered dose per gram of blood. This
was followed by a gradual decrease such that
the concentrations fell by approximately
100-fold over a period of 10 hr. The concen-
tration was 2% of maximum after 6 hr.
The high concentration of BPA was also
detected in maternal liver 10 min after
administration (Figure 2). The maximal
hepatic concentration (171 µg/g; 0.083% of
the dose per gram of liver) was obtained at 20
min, and then decreased by approximately
20-fold over a period of 10 hr. The concen-
tration after 6 hr was 5% of maximum. The
concentration of BPA in liver was 10–100
times higher than in blood. 
The peak BPA concentration (36.2 µg/g;
0.017% of the dose per gram of tissue) in
kidney was also attained 20 min after gavage
(Figure 2), and then decreased by approxi-
mately 50-fold over 10 hr. The concentration
after 6 hr was 5% of maximum. The concen-
tration of BPA in kidney was 10 times higher
than in blood. 
Changes in BPA concentrations in whole
fetuses. In fetuses we found 2.00 µg/g BPA
10 min after administration (Figure 3). BPA
reached the maximal concentration (9.22
µg/g) after 20 min, and then gradually
decreased by approximately 50-fold over 10
hr. The fetal maximal level of BPA was
0.004% of the dose per gram of fetus. The
concentration after 6 hr was 5% of maxi-
mum. The concentration of BPA in fetuses
decreased in almost the same manner as that
in maternal blood.
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Figure 1. HPLC chromatogram of BPA from a fetus 10 min after a single oral dose of 1 g/kg BPA was
administered to a pregnant rat. The fetus was homogenized with 20 mL acetone. The ﬁnal solution for
injection was 10-times concentrated extracts, and the injection volume was 5 µL. Absorbance of a full
scale is 0.01. 
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Figure 2. Changes in bisphenol A concentrations in maternal blood, liver, and kidney over 10–120 min and
0–48 hr after a single oral administration of 1 g/kg bisphenol A to pregnant rats. Points indicate mean ± SD. 
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)Tokicokinetic parameters. We calculated
toxicokinetic parameters using the results
shown above (Table 1). Hepatic AUC was
highest. Fetal AUC was larger than that for
maternal blood. The MRT of maternal
blood was 11 hr, whereas that of fetuses was
20 hr. Fetal VRT was also larger than that
for maternal blood. The initial biologic half-
lives of BPA in maternal organs were
extremely rapid (5.7–14.7 min). Terminal
half-lives in those organs were approximately
2–5 hr. In fetuses, the initial half-life was
rapid (33 min), whereas the terminal half-
life was slightly longer (173 hr). 
Discussion
The results suggest that the absorption and
distribution of BPA in maternal organs and in
fetuses are extremely rapid and that BPA can
easily pass through the placenta. The placenta
is not a barrier to BPA. We investigated a
high dose of 1 g/kg BPA, approximately one-
fourth of the LD50 for rats, to more accurately
determine fetal concentrations by HPLC,
especially when concentrations decreased
afterward. In the case of a lower dose, for
example, 0.1 g/kg, BPA concentrations could
be determined accurately only near peak lev-
els. No toxicologic signs were observed after
the administration of BPA at 1 g/kg. Gross
ﬁndings of internal organs of rats given BPA
were similar to those of the nontreated con-
trol rats. The choice of such a high dose may
raise doubts about the relevance of the biodis-
position data in relation to lower and less
toxic doses. The extremely rapid absorption
and clearance are consistent with other
reported results (21–23) using lower doses
(100–800 mg/kg), so the disposition of this
dose was thought to be representative of lower
and less toxic doses. For substances absorbed
by passive diffusion, the fraction of the dose
absorbed and the kinetics (i.e., the absorption
rate constant) are generally independent of
the administered dose (31). If carrier-mediat-
ed absorption, delayed gastric emptying, or
gastrointestinal mucosal damage can occur,
higher doses may reduce the efﬁciency and
rate of absorption. In the present experiment,
a high dose of BPA was readily absorbed, so
these problems did not occur. Unconjugated
metabolites can increase in the circulation
when chemicals are metabolized and cleared
in the intestines or liver during absorption by
the ﬁrst-pass clearance mechanism. It is possi-
ble that plasma concentrations of unconjugat-
ed BPA are small when low doses of BPA are
administered. As reported by Iguchi (23),
when mice were administered 100 mg/kg
BPA, a considerable amount of unconjugated
BPA was detected in maternal and fetal plas-
ma and organs. Saillenfait et al. (32) reported
that the distribution proﬁle of metabolites in
tissues of pregnant rats was not affected by
increasing the dose of di-n-butyl phthalate
from 0.5 to 1.5 g/kg, whereas the time course
of tissue concentrations was dose-dependent.
The dose-dependent effect was caused by the
saturation of esterase converting di-n-butyl
phthalate into mono-n-butyl phthalate but
not glucuronidase (32). In a study of the dis-
position of thiabendazole, Yoneyhama et al.
(33) also used a large dose (1 g/kg).
Most maternally administered chemicals
have the potential to cross the placenta; the
current question is not whether a chemical
crosses the placenta, but at what rate it does
so (34). Highly lipophilic chemicals are not
necessarily well absorbed via the placenta 
by fetuses. Placental transfer of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD),
polychlorinated biphenyls (PCBs), hydroxy-
lated PCBs, 1,1,1-trichloro-2,2-bis(4-
chlorophenyl)ethane (p,p´-DDT), 1,
1-dichloro-2,2-bis(4-chlorophenyl)ethene
(p,p´-DDE), and pentachlorophenol, with
high octanol/water partition coefﬁcients (log
Pow = 5.0 to 6.0), may be limited or very
slow (35 to 40), although these chemicals can
be accumulated. Chemicals with lower parti-
tion coefﬁcients (logPow=–0.9 to 5.0), such
as diethylstilbestrol (DES), 1,2-diethylben-
zene, mono-n-butyl phthalate, salicylic acid,
1,2-dichloroethane, N,N-dimethylfor-
mamide, and thiabendazole, move relatively
easily across the placenta into fetuses, and the
transfer rate may depend on the structure 
of each compound (32,33,41–45). Their
maximal fetal concentrations are 30–100%
of their maximal maternal plasma levels.
Transplacental absorption may require both
lipophilic and hydrophilic properties; there-
fore, most organic compounds can cross the
placenta. BPA (log Pow = 3.32) can also cross
the placenta at a higher rate, much like thi-
abendazole and salicylic acid (33,42). 
The manner in which fetal BPA levels
become higher than maternal plasma levels
after the maximum maternal plasma level
occurs may resemble that of DES, one of the
most potent nonsteroidal synthetic estrogens
(12). BPA, 2,2-bis(4-hydroxyphenyl)propane,
is somewhat structurally related to DES, 3,4-
bis(4-hydroxyphenyl)-3-hexene. DES is
rapidly absorbed and distributed and cleared
in maternal organs, and its major site of accu-
mulation is the liver (45). Maternally admin-
istered DES is also rapidly distributed to
fetuses in rats, mice, hamsters, and monkeys
(45–49); the fetal level is 2–3 times that in
the maternal blood (50). DES deposits in
fetal genital organs, which may be responsi-
ble for the transplacental reproductive
toxicity (45,47,50). From our results, 
we determined that BPA is also rapidly
absorbed, distributed, and cleared, and the
major organ of accumulation is also the liver.
After 40 min the fetal BPA concentration is
higher than in maternal blood. 
The concentration–time curves of mater-
nal organs and fetuses give clear evidence of
enterohepatic circulation of BPA so that
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Figure 3. Changes in bisphenol A concentrations in whole fetuses over 10–120 min and 0–48 hr after a sin-
gle oral administration of 1 g/kg bisphenol A to pregnant rats. Points indicate mean ± SD. 
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Table 1. The AUC, MRT, VRT, and biologic half-life (t1/2) of maternal blood, liver, and kidneys, and whole
fetus after a single oral administration of bisphenol A at a dose of 1 g/kg to pregnant rats.
Maternal blood Maternal liver Maternal kidney Fetus
AUC (µg·hr/g) 13.1 700 84.0 22.6
MRT (hr) 10.6 29.3 12.0 20.0
VRT (hr2) 203 657 227 419
t1/2 0.0952 (20–40 min)  0.178 (20–40 min) 0.245 (20–40 min) 0.55 (20 min–2 hr)
t1/2 2.58 (40 min–6 hr) 1.75 (40 min–6 hr) 2.98 (1–12 hr) 1.60 (20 min–6 hr)
t1/2 4.65 (6–48 hr) –– 173 (4–48 hr)
The t1/2 was calculated from each linear descending portion during the time (in parentheses). each of the curves shows a secondary peak
after 10 hr (51,52). Approximately 60% of
orally administered BPA is excreted in feces,
with approximately 33% being free BPA,
hydroxylated BPA, or conjugates (21). If the
liver efﬁciently extracts the compound from
the portal blood, the enterohepatic cycling
will involve only the liver and intestine, and
systemic concentrations will increase very lit-
tle (53). However, if the compound is poorly
extracted from the portal blood by the liver,
a signiﬁcant increase in the systemic half-life
can result (20). Most compounds subject to
this cycling may be intermediate between
these two extremes. BPA may also be incor-
porated into the cycle, and its half-life may
be prolonged to some extent.
When a single dose of a chemical is
administered, the MRT is the mean quantity
of a molecular residence time in an organ;
these values can be stochastically handled. In
short, the MRT is the retention time of an
administered chemical in an organ. A small-
er MRT means that the chemical can pass
through more rapidly. The VRT is a vari-
ance of MRT and is the distribution width
of organic concentrations of the chemical. A
larger VRT means that organic concentra-
tions distribute broadly around the MRT.
The AUC is the mass index of the com-
pound incorporated into the body, the
MRT is the rate index of the compound
passing through the body, and the VRT is
the continuation index of the compound in
the body. In the present study, hepatic AUC
was so high that liver could take in BPA.
Because the fetal AUC was higher than that
of maternal blood, fetal intake of BPA was
much greater than maternal blood. The
MRT of maternal blood was 11 hr, whereas
the MRT of fetuses was 20 hr. The fetal
VRT was also larger than that of maternal
blood. Therefore, both mean and maximal
retention times of BPA in fetuses are longer
than in maternal blood.
BPA has been suspected of causing toxic-
ity in male reproductive organs in mice
(16,17,20). Transplacental exposure may
enhance the toxicity in newborn mice (17).
Iguchi (23) showed that BPA was readily
available to fetuses via transplacental uptake
by in mice. The present results agree with
those in mice and clearly indicate a rapid
and sufficient supply of the substance to
fetuses via placenta in pregnant rats. 
The estrogenic activity of BPA at levels
> 200 mg/kg is clear. The toxicokinetic data
after the administration of 1 g/kg BPA may
be generally applied to the doses near 200
mg/kg. Howdeshell et al. (54) demonstrated
that exposure to BPA at 2.4 µg/kg advances
puberty. The problem is whether the present
toxicokinetic results can be applied to this
dose. One of the most important ﬁndings of
our study is that the fetal BPA concentration
can rapidly reach the maximum. The
mechanism of estrogenicity of the lowest
dose is unknown, but the rapid absorption
and distribution in fetuses are certainly
important for those effects. In principle, the
present results may be applicable to lower
and less toxic doses of BPA. 
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